MGI is pleased to announce its participation in the European Congress of Pathology (ECP) 2026, bringing together the pathology community to explore the latest advances shaping the future of diagnostic and translational research.
At ECP 2026, we will showcase new solutions designed to empower pathologists and researchers with innovative genomic and proteomic technologies. From next-generation sequencing to advanced protein analysis, these solutions aim to provide new perspectives on biological mechanisms, disease characterization and precision medicine.
Visitors will have the opportunity to discover our latest innovations and explore how integrating genomics and proteomics can complement established pathology workflows and support increasingly comprehensive approaches to tissue and disease analysis.
Join us at ECP 2026 (booth 332) to discover the latest MGI Tech solutions and discuss how emerging omics technologies can help advance pathology research.
